SU683622A3 - Способ получени производных 1,2-дитиоланов - Google Patents

Способ получени производных 1,2-дитиоланов

Info

Publication number
SU683622A3
SU683622A3 SU772449656A SU2449656A SU683622A3 SU 683622 A3 SU683622 A3 SU 683622A3 SU 772449656 A SU772449656 A SU 772449656A SU 2449656 A SU2449656 A SU 2449656A SU 683622 A3 SU683622 A3 SU 683622A3
Authority
SU
USSR - Soviet Union
Prior art keywords
ethyl
toluene
methyl
solution
alkyl
Prior art date
Application number
SU772449656A
Other languages
English (en)
Russian (ru)
Inventor
Барро Мишель
Котрель Клод
Жанмар Клод
Original Assignee
Рон-Пуленк Эндюстри (Фирма)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7603604A external-priority patent/FR2340730A1/fr
Priority claimed from FR7638901A external-priority patent/FR2374906A2/fr
Application filed by Рон-Пуленк Эндюстри (Фирма) filed Critical Рон-Пуленк Эндюстри (Фирма)
Application granted granted Critical
Publication of SU683622A3 publication Critical patent/SU683622A3/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D241/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with nitrogen atoms directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/08—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/14—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/20—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/38—One sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/12—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/20—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SU772449656A 1976-02-10 1977-02-09 Способ получени производных 1,2-дитиоланов SU683622A3 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7603604A FR2340730A1 (fr) 1976-02-10 1976-02-10 Nouveaux derives du dithiole-1,2, leur preparation et les compositions qui les contiennent
FR7638901A FR2374906A2 (fr) 1976-12-23 1976-12-23 Nouveaux derives du dithiole-1,2, leur preparation et les compositions qui les contiennent

Publications (1)

Publication Number Publication Date
SU683622A3 true SU683622A3 (ru) 1979-08-30

Family

ID=26219294

Family Applications (1)

Application Number Title Priority Date Filing Date
SU772449656A SU683622A3 (ru) 1976-02-10 1977-02-09 Способ получени производных 1,2-дитиоланов

Country Status (26)

Country Link
US (1) US4110450A (fr)
JP (1) JPS5822119B2 (fr)
AR (1) AR224095A1 (fr)
AT (1) AT348535B (fr)
AU (1) AU509092B2 (fr)
CA (1) CA1073906A (fr)
CH (2) CH618699A5 (fr)
DE (1) DE2705641C3 (fr)
DK (1) DK55477A (fr)
EG (1) EG13739A (fr)
ES (3) ES455790A1 (fr)
GB (1) GB1518071A (fr)
HK (1) HK17481A (fr)
HU (1) HU172528B (fr)
IE (1) IE44561B1 (fr)
IL (1) IL51403A (fr)
KE (1) KE3126A (fr)
LU (1) LU76728A1 (fr)
MY (1) MY8200001A (fr)
NL (1) NL171985C (fr)
OA (1) OA05565A (fr)
PH (1) PH12367A (fr)
PT (1) PT66175B (fr)
SE (1) SE427274B (fr)
SU (1) SU683622A3 (fr)
ZM (1) ZM1477A1 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5001125A (en) * 1984-03-26 1991-03-19 Janssen Pharmaceutica N.V. Anti-virally active pyridazinamines
ATE491689T1 (de) * 1997-10-27 2011-01-15 Neurosearch As Heteroaryl diazacycloalkane als cholinergische ligande für nikotin-acetylcholin-rezeptoren
JP2004515453A (ja) 2000-05-05 2004-05-27 ウィスコンシン・アルムナイ・リサーチ・ファウンデーション 癌を化学療法および放射線療法に付する間に細胞を保護するための組成物および方法
KR100491318B1 (ko) * 2002-11-26 2005-05-24 씨제이 주식회사 올티프라즈(Ｏｌｔｉｐｒａｚ) 제조방법
CA2580762A1 (fr) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Derives heterocycliques et leur utilisation comme agents therapeutiques
EP1807085B1 (fr) 2004-09-20 2013-08-21 Xenon Pharmaceuticals Inc. Dérivés hétérocycliques et leur utilisation en tant qu'agents thérapeutiques
EP2289510A1 (fr) 2004-09-20 2011-03-02 Xenon Pharmaceuticals Inc. Dérivés hétérocycliques pour le traitement des maladies induites par des enzymes stearoyl-coa desaturase
AU2005286648A1 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors
CA2580857A1 (fr) 2004-09-20 2006-09-28 Xenon Pharmaceuticals Inc. Derives heterocycliques et leur utilisation en tant qu'agents therapeutiques
US7829712B2 (en) 2004-09-20 2010-11-09 Xenon Pharmaceuticals Inc. Pyridazine derivatives for inhibiting human stearoyl-CoA-desaturase
AR051091A1 (es) 2004-09-20 2006-12-20 Xenon Pharmaceuticals Inc Derivados heterociclicos y su uso como inhibidores de la estearoil-coa desaturasa
AU2006343359A1 (en) 2005-06-03 2007-11-15 Xenon Pharmaceuticals Inc. Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors
WO2009097014A2 (fr) * 2007-08-31 2009-08-06 Cylene Pharmaceuticals, Inc. Modulateurs de kinase thérapeutiques
WO2016207914A2 (fr) * 2015-06-25 2016-12-29 St Ip Holding Ag Procédé de préparation d'oltipraz
US20160376259A1 (en) 2015-06-25 2016-12-29 St Ip Holding Ag Methods for Preparing Oltipraz
WO2018047002A1 (fr) 2016-09-12 2018-03-15 St Ip Holding Ag Formulations de 4-méthyl-5-(pyrazin-2-yl)-3h-1,2-dithiole-3-thione, formulations à goût modifié, et leurs procédés de fabrication et d'utilisation
WO2018047013A1 (fr) 2016-09-12 2018-03-15 St Ip Holding Ag Formulations de 4-méthyl-5-(pyrazine-2-yl)-3 h-1,2-dithiole-3-thione, et leurs procédés de fabrication et d'utilisation
EP3762104A2 (fr) 2018-03-07 2021-01-13 ST IP Holding AG Compositions et thérapies combinées comprenant de la 4-méthyl-5-(pyrazin-2-yl) -3h -1,2-dithiole-3-thione, et procédés de fabrication et d'utilisation associés
US11135220B1 (en) 2020-04-08 2021-10-05 St Ip Holding Ag Methods of treating viral infections with formulated compositions comprising 4-methyl-5-(pyrazin-2-yl)-3H-1,2-dithiole-3-thione

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1526768A (fr) 1963-01-16 1968-05-31 Procédé de préparation de dérivés sulfoniques de dithiole-1, 2 thiones-3 diversement substituées, et applications des produits ainsi obtenus

Also Published As

Publication number Publication date
AU2213877A (en) 1978-08-17
GB1518071A (en) 1978-07-19
CA1073906A (fr) 1980-03-18
EG13739A (en) 1983-03-31
ZM1477A1 (en) 1977-12-21
JPS52113982A (en) 1977-09-24
LU76728A1 (fr) 1977-08-18
AR224095A1 (es) 1981-10-30
DK55477A (da) 1977-08-11
ES458688A1 (es) 1978-07-16
IL51403A0 (en) 1977-04-29
IE44561B1 (en) 1982-01-13
AT348535B (de) 1979-02-26
PH12367A (en) 1979-01-29
NL7701107A (nl) 1977-08-12
CH618699A5 (fr) 1980-08-15
SE427274B (sv) 1983-03-21
KE3126A (en) 1981-05-29
PT66175B (fr) 1978-07-10
US4110450A (en) 1978-08-29
IL51403A (en) 1980-09-16
MY8200001A (en) 1982-12-31
DE2705641B2 (de) 1980-05-08
ATA90277A (de) 1978-07-15
DE2705641A1 (de) 1977-08-11
ES458689A1 (es) 1978-07-16
AU509092B2 (en) 1980-04-17
HU172528B (hu) 1978-09-28
NL171985C (nl) 1983-06-16
ES455790A1 (es) 1978-01-16
JPS5822119B2 (ja) 1983-05-06
SE7701460L (sv) 1977-08-11
CH619463A5 (fr) 1980-09-30
HK17481A (en) 1981-05-08
IE44561L (en) 1977-08-10
OA05565A (fr) 1981-04-30
DE2705641C3 (de) 1981-01-22
PT66175A (fr) 1977-03-01

Similar Documents

Publication Publication Date Title
SU683622A3 (ru) Способ получени производных 1,2-дитиоланов
RU2007403C1 (ru) Способ получения пиразолпиридинового производного или его соли
US4220646A (en) Heterocyclic compounds
ES2325045T3 (es) Nuevos derivados de pirazol heterociclilmetil sustituidos y su uso en el tratamiento de enfermedades cardiovasculares.
JPS60246386A (ja) 新規ピロロ―ベンズイミダゾール、これを含有する心臓―および循環器疾患の予防ないしは治療用医薬
US4613603A (en) Compounds with a nitrogen-containing heterocyclic nucleus, and drugs in which they are present
NO120426B (fr)
JPS6256486A (ja) インド−ル誘導体、その製法及びこれを含有する心臓−及び循環疾病の予防もしくは治療のための薬剤
JPH02288868A (ja) 複素環式化合物およびその製造法
EP0077983B1 (fr) Dérivés de triazine, leur procédé de préparation et les compositions pharmaceutiques les contenant
SU837324A3 (ru) Способ получени производных1,2-диТиОлАНА
NO861266L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridazinon-derivater.
SU862824A3 (ru) Способ получени фенилгидразинопиридазинов
CA1144165A (fr) N-pyrrolyl-pyridazineamines
Mazzone et al. A new synthesis of symmetrical 2, 5‐diaryl‐1, 3, 4‐thiadiazoles
CA1306747C (fr) Procede pour la preparation de derives heterocycliques pouvant etre utilises comme inhibiteurs de l'aldose reductase
SU1440349A3 (ru) Способ получени ортоконденсированных производных пиррола
CA1084929A (fr) 1,2,4-triazolo 4,3-b pyridazin-3-ones
US2835671A (en) Pyridazine derivatives
Katz et al. HYDRAZINE DERIVATIVES. II. ortho-MERCAPTOPYRIDINECARBOHYDRAZIDES
JPH0365349B2 (fr)
HU193276B (en) Process for production of derivatives of arthocondensated pirrole
US4144339A (en) 1,2-Dithiole pyrimidines
JPS5910351B2 (ja) ３−オキシ−１，２，４−トリアゾ−ル誘導体の製造方法
US4145423A (en) Pyrimidinyl-1,2-dithiole compounds and anti-bilharzia compositions thereof